Treatment Arm for Ductal Carcinoma

"This medical trial requires that participants must be between 18 and 95 years old. For those under the age of 18, there are 75 trials available for them to join; alternatively, 2506 clinical studies have been approved for people over 65."

"This medical trial, with its first posting on November 16th 2020, is still recruiting participants according to clinicaltrials.gov and has been recently updated August 27th 2021."

"Based on the evidence compiled by our team at Power, this treatment is given a safety rating of 2 since it is in Phase 2 and there has been some research to indicate its security but no confirmation that it works."

"This medical trial is accepting 20 people affected by carcinoma, ductal between 18 and 95 years old. Mandatory criteria for applying include: being over the age of majority, having an ultrasound-visible mass or nonmass finding that corresponds to a tumor or biopsy marker located within 1cm from the biopsied area; no prior neoadjuvant chemotherapy treatments for breast cancer; breasts large enough for safe cryoablation as determined through clinical exam and imaging; unifocal primary DCIS/ADH bordering on DCIS/DCIS with microinvasion diagnosed by core needle biopsy. Notably, applicants suffering from lobular carcin"

"Affirmative. Evident from the clinicaltrials.gov website, this research endeavour is actively searching for participants after being initially posted on November 16th 2020 and edited as recently as August 27th 2021. The trial calls for 20 patients to be enrolled at two distinct locations."